Canadian application, no grantCanada
Use of soluble tumor necrosis factor receptor for treatment heart failure
CA 2365824 A1 · Owner: Immunex Corporation · Inventors: Hayes, F. Ann
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides methods of treating chronic heart failure in a human patient by repeatedly administering TNFR:Fc for a time sufficient to induce an improvement in an indicator of chronic heart failure.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 28, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 28, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 28, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMarch 28, 2000
GrantedNo grant recorded
Term endedMarch 28, 2020
Patent numberCA 2365824 A1
Classification (IPC)A61K38/17 +1 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.